Product
AV-COVID-19
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 AntibodiesStatus: Withdrawn, Estimated PCD: 2023-06-01